Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan. (Q42953723)
Jump to navigation
Jump to search
scientific article published on August 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan. |
scientific article published on August 2010 |
Statements
Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan (English)
Benedikte Hasselbalch
Helle Broholm
Ib Jarle Christensen
Kirsten Grunnet
Hans Skovgaard Poulsen
Marie-Thérése Stockhausen
1 August 2010
1 reference
1 reference
1 reference
1 reference